SNS Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.2M Buy
46,863
+45,317
+2,931% +$46.3M 1.08% 23
2026
Q1
$1.42M Buy
1,546
+21
+1% +$21.3K 0.12% 70
2025
Q4
$1.64M Buy
1,525
+101
+7% +$96.6K 0.14% 63
2025
Q3
$1.09M Buy
1,424
+6
+0.4% +$4.46K 0.09% 83
2025
Q2
$1.11M Buy
1,418
+41
+3% +$31.9K 0.11% 78
2025
Q1
$1.14M Buy
1,377
+778
+130% +$647K 0.12% 76
2024
Q4
$463K Sell
599
-21
-3% -$17.4K 0.05% 116
2024
Q3
$549K Sell
620
-5
-0.8% -$4.5K 0.06% 112
2024
Q2
$566K Buy
625
+133
+27% +$106K 0.06% 109
2024
Q1
$383K Hold
492
– – 0.04% 130
2023
Q4
$287K Buy
492
+27
+6% +$15.8K 0.03% 148
2023
Q3
$250K Buy
+465
New +$240K 0.03% 154
2022
Q1
– Sell
-8,416
Closed -$2.33M – 241
2021
Q4
$2.33M Buy
8,416
+8
+0.1% +$2.03K 0.25% 60
2021
Q3
$1.94M Buy
8,408
+94
+1% +$23.2K 0.23% 62
2021
Q2
$1.91M Sell
8,314
-376
-4% -$75.5K 0.24% 59
2021
Q1
$1.62M Sell
8,690
-386
-4% -$75.5K 0.22% 69
2020
Q4
$1.53M Sell
9,076
-2,022
-18% -$302K 0.22% 65
2020
Q3
$1.64M Sell
11,098
-391
-3% -$60.5K 0.26% 54
2020
Q2
$1.89M Sell
11,489
-520
-4% -$79.8K 0.34% 48
2020
Q1
$1.67M Sell
12,009
-916
-7% -$126K 0.32% 57
2019
Q4
$1.7M Buy
12,925
+1,218
+10% +$141K 0.3% 56
2019
Q3
$1.31M Sell
11,707
-391
-3% -$43.5K 0.25% 65
2019
Q2
$1.34M Sell
12,098
-568
-4% -$66.9K 0.25% 66
2019
Q1
$1.64M Sell
12,666
-216
-2% -$26.3K 0.36% 50
2018
Q4
$1.49M Buy
+12,882
New +$1.44M 0.37% 54
2015
Q4
– Sell
-6,367
Closed -$533K – 131
2015
Q3
$533K Buy
6,367
+200
+3% +$16.9K 0.15% 79
2015
Q2
$515K Buy
+6,167
New +$470K 0.16% 76

Other funds holding LLY

SNS Financial Group's LLY Position: Q2 2026 in Review

SNS Financial Group increased its Eli Lilly (LLY) stake by 2,931% in Q2 2026, buying an estimated $46.3M and bringing the position to 46,863 shares worth $56.2M. The position accounts for 1.08% of the portfolio, ranked #23.

SNS Financial Group first reported a position in LLY in Q2 2015 and has held it in 27 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SNS Financial Group held 46,863 shares of Eli Lilly worth $56.2M as of Q2 2026.
  • SNS Financial Group bought 45,317 Eli Lilly shares in Q2 2026, an estimated $46.3M.
  • Eli Lilly made up 1.08% of SNS Financial Group's portfolio in Q2 2026, its #23 holding.
  • SNS Financial Group first reported a position in Eli Lilly in Q2 2015 and has held it in 27 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.